Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morning versus bedtime dosing of antihypertensive medication
NCT05089448Phase 4Recruiting
- Sponsor
- Yanli
- Start
- Jan 2021
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of alisartan in hypertension (HTN), sponsored by Yanli. Started Jan 2021; status: recruiting.
02
Drugs
alisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05089448.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05089448.